Announced details
Drug discovery targeting RNA, small-molecule pharmaceuticals targeting mRNA, development of pharmaceuticals addressing unmet medical needs
Nakaya Kazuhiko (中谷和彦) is a senior researcher at the Company. He has been engaged in research activities as a researcher at the Company since April 2026. It states that he and Nakamura Shingo (中村慎吾) have conducted research for 20 years aimed at realizing small-molecule pharmaceuticals targeting mRNA.
Medal with Purple Ribbon
Japan
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | RNA-targeted small-molecule drug discovery, mRNA-targeted small-molecule drug discovery |
| Relationship with the Company | Nakaya Kazuhiko (中谷和彦) is a senior researcher at the Company. He has been engaged in research activities as a researcher at the Company since April 2026. It states that he and Nakamura Shingo (中村慎吾) have conducted research for 20 years aimed at realizing small-molecule pharmaceuticals targeting mRNA. |
| Launch date | April 2026 (actual) |
| Applicable area | Drug discovery targeting RNA, small-molecule pharmaceuticals targeting mRNA, development of pharmaceuticals addressing unmet medical needs |
| Award/certification name | Medal with Purple Ribbon |
| Awarding / certifying body | Japan |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Nakaya Kazuhiko (中谷和彦) has worked for many years on research into interactions between nucleic acids and small-molecule compounds, building a pioneering body of work, particularly in research on small-molecule compounds targeting RNA, and contributing to the development of this field.